Search


	Podcast:		OncLive® On Air
	Episode:		45: Subbiah Tempers Concerns Regarding Pembrolizumab Approval in TMB-High Solid Tumors
	Category:		Science & Medicine
	Duration:		00:20:43
	Publish Date:		2020-10-08 19:53:09
	Description:		In our exclusive interview, Vivek Subbiah, MD, discusses the FDA approval of pembrolizumab in tumor mutational burden–high solid tumors, shares the “transformative importance” of the regulatory decision, and speaks to the controversy surrounding the approval.
	Total Play:		0